$FCSC breakout $4.15 last called 8/9/14 $3.36
Post# of 63692
last called 8/9/14 $3.36
Website
100 % Buy
detailed opinion
Shares Outstanding: 40.86M
Float: 18.93M
% Held by Insiders: 0.67%
% Held by Institutions: 65.60%
Shares Short (as of Jan 30, 2015): 1.75M
Short Ratio (as of Jan 30, 2015): 11.90
Short % of Float (as of Jan 30, 2015): 6.80%
Shares Short (prior month): 1.86M
Recent trades
Headlines
Monday, January 12, 2015
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Wednesday, January 7, 2015
Fibrocell Science to Present at Biotech Showcase 2015 ConferenceGlobeNewswire (Wed, Jan 7)
Tuesday, November 18, 2014
Fibrocell Science Announces IND Allowed to Proceed to Develop New Treatment for Wounded Warrior Amputees to Prevent Stump Skin DiseasesGlobeNewswire (Tue, Nov 18)
Saturday, November 15, 2014
FIBROCELL SCIENCE, INC. FinancialsEDGAR Online Financials (Sat, Nov 15)
Friday, November 7, 2014
Fibrocell Science posts 3Q lossAP (Fri, Nov 7)
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online (Fri, Nov 7)
Tuesday, October 14, 2014
Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4%Zacks (Tue, Oct 14)
Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5%Zacks (Tue, Oct 14)
Monday, October 13, 2014
Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8%Zacks (Mon, Oct 13)
Nanosphere (NSPH) Soars: Stock Adds 26.6% in SessionZacks (Mon, Oct 13)
Friday, October 3, 2014
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Oct 3)
Tuesday, September 30, 2014
Fibrocell Science to Present at 2014 Stem Cell Meeting on the MesaBusiness Wire (Tue, Sep 30)
Thursday, September 25, 2014
Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry ConferenceBusiness Wire (Thu, Sep 25)
Wednesday, September 24, 2014
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Sep 24)
Fibrocell Science and Intrexon Advance GM-HDF-COL7 toward Clinical Development for the Treatment of Recessive Dystrophic Epidermolysis BullosaBusiness Wire (Wed, Sep 24)
Wednesday, September 10, 2014
Fibrocell Science Hosting R&D Day on September 24, 2014Business Wire (Wed, Sep 10)
Wednesday, September 3, 2014
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibEDGAR Online (Wed, Sep 3)
Thursday, August 28, 2014
How Fibrocell Science (FCSC) Stock Stands Out in a Strong IndustryZacks (Thu, Aug 28)
Monday, August 18, 2014
FIBROCELL SCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StaEDGAR Online (Mon, Aug 18)
Fibrocell Science, Inc. to Move Stock Listing to NASDAQBusiness Wire (Mon, Aug 18)